User profiles for J. M. Flynn

John M. Flynn, MD

- Verified email at chop.edu - Cited by 16793

Julia Flynn

- Verified email at umassmed.edu - Cited by 2860

Jullien Flynn

- Verified email at wi.mit.edu - Cited by 1889

Invited review article: Strategies and processes for high quality wire arc additive manufacturing

CR Cunningham, JM Flynn, A Shokrani, V Dhokia… - Additive …, 2018 - Elsevier
Wire Arc Additive Manufacturing (WAAM) is attracting significant attention in industry and
academia due to its ability to capture the benefits of additive manufacturing for production of …

[HTML][HTML] Sculpting the proteome with AAA+ proteases and disassembly machines

RT Sauer, DN Bolon, BM Burton, RE Burton, JM Flynn… - Cell, 2004 - cell.com
Abstract Machines of protein destruction—including energy-dependent proteases and
disassembly chaperones of the AAA+ ATPase family—function in all kingdoms of life to sculpt the …

Hybrid additive and subtractive machine tools–Research and industrial developments

JM Flynn, A Shokrani, ST Newman, V Dhokia - International Journal of …, 2016 - Elsevier
By synergistically combining additive and subtractive processes within a single workstation,
the relative merits of each process may be harnessed. This facilitates the manufacture of …

RepeatModeler2 for automated genomic discovery of transposable element families

JM Flynn, R Hubley, C Goubert… - Proceedings of the …, 2020 - National Acad Sciences
The accelerating pace of genome sequencing throughout the tree of life is driving the need
for improved unsupervised annotation of genome components such as transposable …

Titanium elastic nails for pediatric femur fractures: a multicenter study of early results with analysis of complications

JM Flynn, T Hresko, RAK Reynolds… - Journal of Pediatric …, 2001 - journals.lww.com
Titanium elastic nailing is used instead of traction and casting in many European centers,
but limited availability has prevented widespread use in North America. Before a planned …

Ibrutinib is an irreversible molecular inhibitor of ITK driving a Th1-selective pressure in T lymphocytes

…, LL Smith, KA Smucker, JM Flynn… - Blood, The Journal …, 2013 - ashpublications.org
Given its critical role in T-cell signaling, interleukin-2–inducible kinase (ITK) is an appealing
therapeutic target that can contribute to the pathogenesis of certain infectious, autoimmune, …

[PDF][PDF] Proteomic discovery of cellular substrates of the ClpXP protease reveals five classes of ClpX-recognition signals

JM Flynn, SB Neher, YI Kim, RT Sauer, TA Baker - Molecular cell, 2003 - cell.com
ClpXP is a protease involved in DNA damage repair, stationary-phase gene expression, and
ssrA-mediated protein quality control. To date, however, only a handful of ClpXP substrates …

Phosphatidylinositol 3-kinase-δ inhibitor CAL-101 shows promising preclinical activity in chronic lymphocytic leukemia by antagonizing intrinsic and extrinsic cellular …

…, NA Heerema, W Zhao, JM Flynn… - Blood, The Journal …, 2010 - ashpublications.org
Targeted therapy with imatinib in chronic myeloid leukemia (CML) prompted a new treatment
paradigm. Unlike CML, chronic lymphocytic leukemia (CLL) lacks an aberrant fusion …

Physical results from flavor domain wall QCD and SU(2) chiral perturbation theory

…, SD Cohen, C Dawson, MA Donnellan, JM Flynn… - Physical Review D, 2008 - APS
We have simulated QCD using 2+ 1 flavors of domain wall quarks and the Iwasaki gauge
action on a (2.74 fm) 3 volume with an inverse lattice scale of a− 1= 1.729 (28) GeV. The up …

Etiology of ibrutinib therapy discontinuation and outcomes in patients with chronic lymphocytic leukemia

…, LL Smith, R Mantel, JA Jones, JM Flynn… - JAMA …, 2015 - jamanetwork.com
Importance The Bruton tyrosine kinase (BTK) inhibitor ibrutinib is effective in patients with
chronic lymphocytic leukemia (CLL). Reasons for discontinuing therapy with this drug and …